Category: Healthcare
Central America Healthcare
-
Costa Rica Pharmaceuticals & Healthcare Q3 2019
... treatment and the gradual launch of new therapies will support this trend.Costa Rica will continue to represent a stable operating environment in Latin America although the relatively small market size willcontinue to weigh on the ... Read More
-
Panama Pharmaceuticals & Healthcare Q3 2019
... recurrent medicine shortages and risingmedicine prices, the incoming government will likely place particular attention on these and other issues arising in part from thelack of a unified public health system and inefficient regulatory processes. Panama’s ... Read More
-
El Salvador Pharmaceuticals & Healthcare Q2 2019
... slow but steady improvement to pharmaceutical production infrastructureand intellectual property provisions. However, owing to a persistent lack of coordination, underdeveloped informationsystems and financial instability, the health sector has been unable to exploit the country's abundant ... Read More
-
Guatemala Pharmaceuticals & Healthcare Q2 2019
... constraints will remain a recurrent issue. This will bepartially addressed by new healthcare infrastructure projects announced by the social security institute. Government steps towardsunifying the health system will progress at a gradual pace, limiting significant ... Read More
-
Nicaragua Pharmaceuticals & Healthcare Q2 2019
... and long-term, the sector will remain heavily underfunded. Withthe government cutting funding for numerous healthcare projects along with the mass dismissals of medical professionals inretaliation to wide spread unrest in 2018, patient access to health ... Read More
-
Honduras Pharmaceuticals & Healthcare Q2 2019
... the market will remainreliant on low-value generic imports. We expect weak growth for medicine sales in the coming years, as institutional corruption andan inadequate regulatory enforcement will continue to make Honduras one of the least ... Read More
-
Herbal/Traditional Products in Costa Rica
... Himalaya have been capable of developing top-of-mind awareness across different groups of target buyers, who often base their choices on positive references, point-of-sale presence and affordability. Functional herbal formulations for common modern ailments such as ... Read More
-
Herbal/Traditional Products in Guatemala
... as a large part of the population lives below the poverty line without easy access to medication, and cultural, as Guatemalans see herbal/traditional products as effective, but harmless options. The low unit price of herbs ... Read More
-
Medical Tourism Market Size, Share & Trends Analysis Report By Country (Costa Rica, Mexico, India, Thailand, Malaysia, and Singapore), Competitive Landscape, and Segment Forecasts, 2018 - 2025
... expected to reach USD 131.35 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 20.24% during the forecast period. Growing geriatric population coupled with improving accessibility ... Read More
-
Guatemala Pharmaceuticals & Healthcare Q2 2018
... that demand for medical treatment remains on the rise. Morebroadly, the relatively large and growing population will drive commercial opportunities for drugmakers and healthcare suppliers.However, low per capita spending on medicine and a poor operating ... Read More
-
Guatemala Pharmaceuticals & Healthcare Report Q4 2017
... to weigh on business sentiment in the near term. In fact, corruption allegations against administration officials will continue to undermine government efforts to boost growth through infrastructure development projects, translating into limited bidders for public ... Read More
-
El Salvador Pharmaceuticals and Healthcare Report Q4 2017
... of Health's efforts to solicit outside assistance to bolster healthcareprovision in all quarters of the country. Despite improvements in the regulatory environment since TheMedicines Law of El Salvador was approved in 2012, steady multinational FDI ... Read More
-
Costa Rica Pharmaceuticals and Healthcare Report Q4 2017
... medical tourism destination and expandinghealthcare infrastructure that will need to cater to its gradually ageing population. However, the smallmarket size will continue to hamper its growth potential as well as its relative attractiveness. Headline Expenditure ... Read More
-
Nicaragua Pharmaceuticals and Healthcare Report Q4 2017
... of the overallmarket is among the smallest in Central America and is limited by a largely low-income population with astrong preference for traditional medicines. Furthermore, weak drug regulatory framework and poorhealthcare infrastructure will dampen multinational ... Read More
-
Honduras Pharmaceuticals and Healthcare Report Q4 2017
... weak regulatory environment and low levels of affordability will hold back innovativemedicine sales. We expect low-cost generic medicines will continue to dominate the market as thegovernment looked to improve healthcare coverage within a limited budget. ... Read More
-
Panama Pharmaceuticals and Healthcare Report Q4 2017
... by regionalstandards, Panama will continue to create commercial opportunities for foreign drugmakers given risingdemand for chronic disease treatment and the limited local drug manufacturing capacity. However, genericmedicine usage will remain relatively high despite high spending ... Read More
-
CCSS/APHNN – Torre Esperanza Children Hospital Development – Costa Rica Project Profile
... project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The "CCSS/APHNN – Torre Esperanza Children Hospital ... Read More
-
MS – Hospital Panama Norte – Panama Project Profile
... also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The "MS – Hospital Panama Norte – Panama Project Profile" is part of ... Read More
-
HDN – Children Hospital – Panama City Project Profile
... also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The "HDN – Children Hospital – Panama City Project Profile" is part of ... Read More
-
Guatemala Pharmaceuticals and Healthcare Report Q2 2016
... However, in spite of this, the country will continue to attract investment as a regionalpharmaceutical production hub. Since the end of the 36-year civil war in 1996, Guatemala's politicalstability has been progressing and tax incentives ... Read More
-
Panama Pharmaceuticals and Healthcare Report Q2 2016
... the country over the long term.The planned operational enhancements will also increase medicine consumption and demand forhealthcare supplies, thus improving the country's appeal to foreign investors. The strong trade environmentdue to the Colon Free Trade ... Read More
-
Nicaragua Pharmaceuticals and Healthcare Report Q2 2016
... a small andunregulated drug market and the socio-cultural preference for traditional medicines will present limitedopportunities for innovative drugmakers.Headline Expenditure ProjectionsPharmaceuticals: NIO10.93bn (USDb401mn) in 2015 to NIO11.42bn (USD399mn) in 2016; +4.3% inlocal currency terms, and -0.7% ... Read More
-
Honduras Pharmaceuticals and Healthcare Report Q2 2016
... local market. Thepharmaceutical market in Honduras will continue to be extremely unattractive to multinational drugmakersdue to the small market size, low growth rate and the fragmented, opaque and often-questionable publicprocurement process. Headline Expenditure Projections Pharmaceuticals: ... Read More
-
Costa Rica Pharmaceuticals and Healthcare Report Q2 2016
... CostaRica will continue to provide a business friendly environment for pharmaceutical companies to invest in thelocal market. Headline Expenditure Projections Pharmaceuticals: CRC446.9bn (USD813mn) in 2015 to CRC469.5bn (USD861mn) in 2016; +5.0% inlocal currency terms and ... Read More
-
Central America Pharmaceuticals and Healthcare Report Q1 2016
... ageing population and dependence on pharmaceutical imports will increase foreign investmentappeal as public health provision grows. Headline Expenditure Projections Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +4.6%. Our forecast has been maintainedsince Q115. Healthcare: ... Read More
Research Assistance
